---
figid: PMC9025408__ijms-23-04431-g005
pmcid: PMC9025408
image_filename: ijms-23-04431-g005.jpg
figure_link: /pmc/articles/PMC9025408/figure/ijms-23-04431-f005/
number: Figure 5
figure_title: ''
caption: 'Effect of Dio on the activation of TLR4-MyD88-NF-κB signaling pathway and
  immune-inflammation status in rats with CDDP-induced mucositis. Changes in the relative
  protein expression levels of TLR4 (A), MyD88 (B), p-NF-κB/NF-κB ratio (C) and p-IκBα/IκBα
  ratio (D). (E) Representative Western blotting images of TLR4, MyD88, p-NF-κB, NF-κB,
  p-IκBα and IκBα. (F) Relative mRNA expression of TLR4, MyD88, NF-κB and IκBα. Changes
  in the relative protein expression levels of TNFα (G), Pro-IL1β & IL1β (H), IL6
  (I) and IL10 (J). (K) Representative Western blotting images of TNFα, Pro-IL1β,
  IL1β, IL6 and IL10. (L) Relative mRNA expression of TNF-α, IL-1β, IL-6 and IL-10.
  * p < 0.05, ** p < 0.01 vs. control group, # p < 0.05, ## p < 0.01 vs. CDDP group.'
article_title: Dioscin Alleviates Cisplatin-Induced Mucositis in Rats by Modulating
  Gut Microbiota, Enhancing Intestinal Barrier Function and Attenuating TLR4/NF-κB
  Signaling Cascade.
citation: Shengzi Jin, et al. Int J Mol Sci. 2022 Apr;23(8):4431.
year: '2022'

doi: 10.3390/ijms23084431
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- dioscin
- cisplatin
- mucositis
- gut microbiota
- intestinal barrier
- TLR4-MyD88-NF-κB

---
